JChidiac at 19:09, 24 February 2015

2015-02-24T19:09:11Z

Adm1n: Created page with "'''JWH-210''' is an analgesic chemical from the naphthoylindole family, which acts as a potent cannabinoid agonist at both the CB1 and CB2 receptors, with Ki value..."

2015-02-15T12:26:28Z

Created page with "'''JWH-210''' is an analgesic chemical from the naphthoylindole family, which acts as a potent cannabinoid agonist at both the CB1 and CB2 receptors, with Ki value..."

New page

'''JWH-210''' is an analgesic chemical from the naphthoylindole family, which acts as a potent [[cannabinoid]] agonist at both the [[CB1]] and [[CB2 receptor]]s, with Ki values of 0.46nM at CB1 and 0.69nM at CB2. It is one of the most potent 4-substituted naphthoyl derivatives in the naphthoylindole series, having a higher binding affinity (i.e. lower Ki) at CB1 than both its 4-methyl and 4-n-propyl homologues [[JWH-122]] (CB1 Ki 0.69nM) and JWH-182 (CB1 Ki 0.65nM) respectively, and than the 4-methoxy compound [[JWH-081]] (CB1 Ki 1.2nM). It was discovered by and named after Dr. John W. Huffman. JWH-210 and JWH-122 were banned in Sweden on 1 October 2010 as hazardous goods harmful to health, after being identified as ingredients in "herbal" synthetic cannabis products. The substances JWH-210, JWH-122 and [[JWH-203]] were classified as illegal drugs by the Swedish government as of 1 September 2011.

==See also==

*[[JWH-081]]
*[[JWH-193]]
*[[JWH-398]]

← Older revision		Revision as of 19:09, 24 February 2015
Line 1:		Line 1:
	'''JWH-210''' is an analgesic chemical from the naphthoylindole family, which acts as a potent [[cannabinoid]] agonist at both the [[CB1]] and [[CB2 receptor]]s, with Ki values of 0.46nM at CB1 and 0.69nM at CB2. It is one of the most potent 4-substituted naphthoyl derivatives in the naphthoylindole series, having a higher binding affinity (i.e. lower Ki) at CB1 than both its 4-methyl and 4-n-propyl homologues [[JWH-122]] (CB1 Ki 0.69nM) and JWH-182 (CB1 Ki 0.65nM) respectively, and than the 4-methoxy compound [[JWH-081]] (CB1 Ki 1.2nM). It was discovered by and named after Dr. John W. Huffman. JWH-210 and JWH-122 were banned in Sweden on 1 October 2010 as hazardous goods harmful to health, after being identified as ingredients in "herbal" synthetic cannabis products. The substances JWH-210, JWH-122 and [[JWH-203]] were classified as illegal drugs by the Swedish government as of 1 September 2011.		'''JWH-210''' is an analgesic chemical from the naphthoylindole family, which acts as a potent [[cannabinoid]] agonist at both the [[CB1]] and [[CB2 receptor]]s, with Ki values of 0.46nM at CB1 and 0.69nM at CB2. It is one of the most potent 4-substituted naphthoyl derivatives in the naphthoylindole series, having a higher binding affinity (i.e. lower Ki) at CB1 than both its 4-methyl and 4-n-propyl homologues [[JWH-122]] (CB1 Ki 0.69nM) and JWH-182 (CB1 Ki 0.65nM) respectively, and than the 4-methoxy compound [[JWH-081]] (CB1 Ki 1.2nM). It was discovered by and named after Dr. John W. Huffman. JWH-210 and JWH-122 were banned in Sweden on 1 October 2010 as hazardous goods harmful to health, after being identified as ingredients in "herbal" synthetic cannabis products. The substances JWH-210, JWH-122 and [[JWH-203]] were classified as illegal drugs by the Swedish government as of 1 September 2011.
		+
		+	[[File:JWH-210_structure.png]]

	==See also==		==See also==

JWH-210 - Revision history

JChidiac at 19:09, 24 February 2015

Adm1n: Created page with "'''JWH-210''' is an analgesic chemical from the naphthoylindole family, which acts as a potent cannabinoid agonist at both the CB1 and CB2 receptors, with Ki value..."